Amgen: Accelerating The Business & Dividend Growth (NASDAQ:AMGN)


Biology laboratory nature and science, Plants with biochemistry structure on green background.


Amgen Inc. (NASDAQ:AMGN) has an impressive total return and dividend growth track record with a solid financial foundation, but faces operational challenges under the burden of significant investment. While this could undermine its dividend growth performance long term, I believe


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *